Central to the mission of the Koch Institute is to understand the molecular and cellular changes associated with cancer development and progression and to apply that knowledge to developing new treatments and diagnostic approaches. Advanced state-of-the-art imaging tools are essential for these studies. The Koch Institute Microscopy Core provides a broad range of light microscopy-based imaging systems and related image analysis platforms that enable both ex vivo and intravital imaging of nanoparticles, cells, tissues and tumors. In the current funding period, the capabilities of this Core have been expanded and enhanced. This includes the acquisition of new instrumentation and upgrades to many imaging systems, with support from Institutional funding. Importantly, we have recruited Dr. Jeffrey Kuhn to the Core Leader position. Dr. Kuhn is an interdisciplinary expert in cell biology, single molecule biochemistry, and imaging instrument and software development. Core use by Koch Institute Investigators has been strong during this funding cycle: 77% of Center Members use the Core, account for 94% of Core service use, and include investigators from all three Research Programs. In the upcoming funding period, the Microscopy Core will continue to offer a wide range of state-of-the-art services to support Center Member research programs. The Microscopy Core is committed to maintaining instrumentation and capabilities at the leading edge, and will continue to closely monitor technological improvements and evaluate emerging capabilities in the context of Center Member needs and interests. A primary goal is to conduct a hands-on and complete assessment of Core capabilities and Center Member needs with respect to both instrumentation and data analysis capabilities. Replacement of older instruments and acquisition of new capabilities and upgrades will be guided by Center Member research needs and will be funded by Institutional sources. Specific planned initiatives include: enhancing expertise in single molecule localization microscopy; expanding hands-on training opportunities; developing resources to support advanced image processing, visualization, quantitation and machine learning; and collaborating with other Koch Institute Cores to develop a monthly workshop series to support Center Members? access to imaging technology platforms and data analysis. This Shared Resource is essential to the success of the Koch Institute mission and provides exceptional value to the CCSG. The requested CCSG budget for Year 49 is increased by 27.2% over the Core CCSG budget for the current period (Year 48), reflecting increased support for expert personnel. The CCSG budgets of other Koch Institute Cores have been reduced to offset the proposed increase in this, and other, Cores.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014051-49
Application #
9937094
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
49
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Weidberg, Hilla; Amon, Angelika (2018) MitoCPR-A surveillance pathway that protects mitochondria in response to protein import stress. Science 360:
Chiu, Anthony C; Suzuki, Hiroshi I; Wu, Xuebing et al. (2018) Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed by U1 snRNP. Mol Cell 69:648-663.e7
Nagarajan, Maxwell B; Tentori, Augusto M; Zhang, Wen Cai et al. (2018) Nonfouling, Encoded Hydrogel Microparticles for Multiplex MicroRNA Profiling Directly from Formalin-Fixed, Paraffin-Embedded Tissue. Anal Chem 90:10279-10285
Mead, Benjamin E; Ordovas-Montanes, Jose; Braun, Alexandra P et al. (2018) Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types. BMC Biol 16:62
Chen, Tiffany F; Li, Kevin K; Zhu, Eric F et al. (2018) Artificial Anti-Tumor Opsonizing Proteins with Fibronectin Scaffolds Engineered for Specificity to Each of the Murine Fc?R Types. J Mol Biol 430:1786-1798
Dayton, Talya L; Gocheva, Vasilena; Miller, Kathryn M et al. (2018) Isoform-specific deletion of PKM2 constrains tumor initiation in a mouse model of soft tissue sarcoma. Cancer Metab 6:6
Koblan, Luke W; Doman, Jordan L; Wilson, Christopher et al. (2018) Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol 36:843-846
Suarez-Lopez, Lucia; Sriram, Ganapathy; Kong, Yi Wen et al. (2018) MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis. Proc Natl Acad Sci U S A 115:E4236-E4244
Guner-Ataman, Burcu; González-Rosa, Juan Manuel; Shah, Harsh N et al. (2018) Failed Progenitor Specification Underlies the Cardiopharyngeal Phenotypes in a Zebrafish Model of 22q11.2 Deletion Syndrome. Cell Rep 24:1342-1354.e5
Phizicky, David V; Berchowitz, Luke E; Bell, Stephen P (2018) Multiple kinases inhibit origin licensing and helicase activation to ensure reductive cell division during meiosis. Elife 7:

Showing the most recent 10 out of 904 publications